beauty health co - SKIN

SKIN

Close Chg Chg %
1.44 -0.01 -0.69%

Closed Market

1.43

-0.01 (0.69%)

Volume: 301.41K

Last Updated:

Dec 30, 2025, 4:00 PM EDT

Company Overview: beauty health co - SKIN

SKIN Key Data

Open

$1.44

Day Range

1.41 - 1.45

52 Week Range

0.78 - 2.69

Market Cap

$183.60M

Shares Outstanding

127.50M

Public Float

76.98M

Beta

1.18

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.09

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

674.19K

 

SKIN Performance

1 Week
 
-1.37%
 
1 Month
 
-2.70%
 
3 Months
 
-14.29%
 
1 Year
 
-9.43%
 
5 Years
 
-87.27%
 

SKIN Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 9
Full Ratings ➔

About beauty health co - SKIN

The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. Its brands include Hydrafacial, SkinStylus, and Keravive. The company was founded in 1997 and is headquartered in Long Beach, CA.

SKIN At a Glance

The Beauty Health Co.
2165 Spring Street
Long Beach, California 90806
Phone 1-800-603-4996 Revenue 334.29M
Industry Medical Specialties Net Income -29,098,000.00
Sector Health Technology Employees 769
Fiscal Year-end 12 / 2025
View SEC Filings

SKIN Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.678
Price to Book Ratio 3.834
Price to Cash Flow Ratio 14.04
Enterprise Value to EBITDA -14.017
Enterprise Value to Sales 1.27
Total Debt to Enterprise Value 1.338

SKIN Efficiency

Revenue/Employee 434,712.614
Income Per Employee -37,838.752
Receivables Turnover 11.347
Total Asset Turnover 0.414

SKIN Liquidity

Current Ratio 7.001
Quick Ratio 5.987
Cash Ratio 5.43

SKIN Profitability

Gross Margin 56.925
Operating Margin -17.881
Pretax Margin -8.84
Net Margin -8.704
Return on Assets -3.604
Return on Equity -52.338
Return on Total Capital -4.694
Return on Invested Capital -4.093

SKIN Capital Structure

Total Debt to Total Equity 1,096.767
Total Debt to Total Capital 91.644
Total Debt to Total Assets 82.86
Long-Term Debt to Equity 1,086.831
Long-Term Debt to Total Capital 90.814
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Beauty Health Co - SKIN

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
260.09M 365.88M 397.99M 334.29M
Sales Growth
- +40.68% +8.78% -16.00%
Cost of Goods Sold (COGS) incl D&A
85.73M 121.53M 242.88M 144.00M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
21.14M 26.58M 32.24M 29.48M
Depreciation
7.84M 11.72M 11.33M 9.94M
Amortization of Intangibles
13.30M 14.85M 20.91M 19.54M
COGS Growth
- +41.76% +99.85% -40.71%
Gross Income
174.36M 244.35M 155.11M 190.30M
Gross Income Growth
- +40.14% -36.52% +22.68%
Gross Profit Margin
+67.04% +66.78% +38.97% +56.92%
2021 2022 2023 2024 5-year trend
SG&A Expense
172.07M 247.40M 278.83M 250.07M
Research & Development
8.20M 8.44M 10.10M 6.30M
Other SG&A
163.87M 238.96M 268.73M 243.77M
SGA Growth
+14,125.62% +43.78% +12.70% -10.31%
Other Operating Expense
- - - -
-
Unusual Expense
363.05M (56.96M) (4.72M) 4.93M
EBIT after Unusual Expense
(360.75M) 53.91M (119.00M) (64.71M)
Non Operating Income/Expense
(4.82M) 4.52M 30.76M 45.57M
Non-Operating Interest Income
- 9.18M 23.17M 16.64M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
11.78M 13.39M 13.65M 10.41M
Interest Expense Growth
- +13.71% +1.92% -23.72%
Gross Interest Expense
11.78M 13.39M 13.65M 10.41M
Interest Capitalized
- - - -
-
Pretax Income
(377.35M) 45.03M (101.89M) (29.55M)
Pretax Income Growth
-33,854.57% +111.93% -326.26% +71.00%
Pretax Margin
-145.09% +12.31% -25.60% -8.84%
Income Tax
(2.24M) 648.00K (1.77M) (452.00K)
Income Tax - Current - Domestic
(214.00K) 713.00K 250.00K 142.00K
Income Tax - Current - Foreign
1.74M 1.72M 3.79M 3.00M
Income Tax - Deferred - Domestic
- (3.40M) (423.00K) (4.77M)
Income Tax - Deferred - Foreign
(364.00K) (1.36M) (1.05M) (3.60M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(375.11M) 44.38M (100.12M) (29.10M)
Minority Interest Expense
- - - -
-
Net Income
(375.11M) 44.38M (100.12M) (29.10M)
Net Income Growth
-33,652.83% +111.83% -325.57% +70.94%
Net Margin Growth
-144.22% +12.13% -25.16% -8.70%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(375.11M) 44.38M (100.12M) (29.10M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(375.11M) 44.38M (100.12M) (29.10M)
EPS (Basic)
-3.6734 0.3008 -0.7603 -0.235
EPS (Basic) Growth
-18,933.16% +108.19% -352.76% +69.09%
Basic Shares Outstanding
102.11M 147.55M 131.68M 123.83M
EPS (Diluted)
-3.6734 -0.2287 -0.7603 -0.3633
EPS (Diluted) Growth
-18,933.16% +93.77% -232.44% +52.22%
Diluted Shares Outstanding
102.11M 148.51M 131.68M 142.49M
EBITDA
23.43M 23.52M (91.48M) (30.30M)
EBITDA Growth
+2,036.75% +0.41% -488.90% +66.88%
EBITDA Margin
+9.01% +6.43% -22.98% -9.06%

Snapshot

Average Recommendation HOLD Average Target Price 1.933
Number of Ratings 9 Current Quarters Estimate -0.046
FY Report Date 12 / 2025 Current Year's Estimate -0.068
Last Quarter’s Earnings -0.09 Median PE on CY Estimate N/A
Year Ago Earnings -0.23 Next Fiscal Year Estimate -0.123
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 5 9 9
Mean Estimate -0.05 -0.03 -0.07 -0.12
High Estimates -0.02 0.03 0.01 0.10
Low Estimate -0.08 -0.06 -0.19 -0.35
Coefficient of Variance -50.08 -115.67 -82.11 -104.34

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 6 6 6
UNDERWEIGHT 0 0 0
SELL 2 2 2
MEAN Hold Hold Hold

Insider Actions for Beauty Health Co - SKIN

Date Name Shares Transaction Value
Aug 13, 2025 Michael P. Monahan Chief Financial Officer 1,326,305 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.89 per share 2,506,716.45
Mar 21, 2025 Marla Malcolm Beck President and CEO; Director 2,846,382 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $1.32 per share 3,757,224.24
Mar 21, 2025 Sheri Lewis CSO and COO 946,022 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $1.32 per share 1,248,749.04
Mar 21, 2025 Ronald Menezes Chief Revenue Officer 1,121,131 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $1.32 per share 1,479,892.92

Beauty Health Co in the News